Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis

NCT04614610 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Sickle Cell Crisis
Pain, Acute

Interventions

DRUG: Lidocaine Iv
DRUG: Placebo

Sponsor

Community Medical Center, Toms River, NJ

Collaborators

[object Object]
[object Object]
[object Object]